Skip to main content

GOLDMAN SACHS GROUP INC

Position in MLTX — MoonLake Immunotherapeutics

CIK 886982 NEW YORK, NY

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,520,079
-$18,547,464 QoQ
Shares Held
129,434
-88.5% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 172 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. MLTX ranks #220 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MLTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,520,079 129,434
2026-03-31 $21,067,543 1,130,233
2025-12-31 $3,567,364 270,665
2025-09-30 $2,601,785 362,871
2025-06-30 $60,206,856 1,275,569
2025-03-31 $50,502,193 1,292,608
2024-12-31 $90,683,055 1,674,664
2024-09-30 $75,419,798 1,495,831
2024-06-30 $55,039,314 1,251,747
2024-03-31 $7,944,376 158,160
2023-12-31 $9,126,981 151,134
2023-09-30 $5,511,159 96,687
2023-06-30 $4,564,551 89,501
2022-12-31 $106,155 10,110
2022-09-30 $79,229 10,210
2022-06-30 $61,871 11,785